Comprehensive MELARIS®
GENETIC VARIANT, FAVOR POLYMORPHISM
 This result means that the test identified a common genetic change in p16 that is presumed, but not yet conclusively proven, to be unrelated to hereditary cancer risk. The term polymorphism refers to genetic variations that are present in at least 1% of the general population and are unrelated to a significantly increased risk of disease. A patient with this result should be managed in the same manner as a patient with a no mutation detected result. Click here for information on a no mutation detected result.
Download the Results Patient Education Tool
MELARIS® No Mutation Detected or Favor Polymorphism
A favor polymorphism result may be reclassified as a definitive no mutation detected by Myriad in the future. If this occurs, Myriad will issue an amended report to the healthcare provider who ordered the test.
« Back to the MELARIS® Test Results page
|
